Sustainability Advantage Dividella emphasizes mono-material packaging, optimized cold-chain sizes, and a modular, sustainable design, presenting a compelling opportunity to position them as a provider of cost-efficient, compliant packaging solutions for pharma and biotech customers seeking sustainability and reduced total cost of ownership.

Top-Heavy Target With 30 years of experience and a client base including most of the top 30 pharma manufacturers, there is a strong narrative for expanding into large biotech and pharmaceutical accounts that require specialized secondary packaging systems for vials, ampoules, syringes, and pens.

Cold Chain Fit Solutions are optimized for cold-chain packaging, which aligns with the growing demand for temperature-controlled pharmaceutical products; this creates cross-sell opportunities into manufacturers expanding biologics and mRNA products that demand reliable cold-chain packaging.

Cost of Ownership Emphasize the low total cost of ownership and end-user ease of use to drive conversations about switching from incumbent systems, highlighting potential savings through standardized packaging, mono-material design, and streamlined compliance and handling.

Digital & Partnerable Leverage Dividella’s tech stack and ongoing customer advisory approach to offer integrated digital packaging design and optimization services, and explore partnerships or pilots with larger packaging or contract manufacturers seeking modular, scalable secondary packaging solutions.